ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 62 filers reported holding ARYA SCIENCES ACQU CORP IV in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,833,000 | -10.6% | 285,730 | -11.5% | 0.18% | +15.1% |
Q2 2022 | $3,168,000 | -0.8% | 322,929 | -0.9% | 0.16% | +12.8% |
Q1 2022 | $3,193,000 | -19.3% | 325,848 | -18.4% | 0.14% | +1.4% |
Q4 2021 | $3,959,000 | -1.3% | 399,248 | 0.0% | 0.14% | +10.3% |
Q3 2021 | $4,012,000 | -6.4% | 399,248 | -0.2% | 0.13% | +3.3% |
Q2 2021 | $4,288,000 | +2.4% | 400,000 | 0.0% | 0.12% | 0.0% |
Q1 2021 | $4,189,000 | – | 400,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 600,000 | $6,036,000 | 1.52% |
Cohen & Co Financial Management, LLC | 250,000 | $2,513,000 | 1.05% |
ATW SPAC MANAGEMENT LLC | 500,000 | $5,025,000 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 1,000,000 | $10,060,000 | 0.84% |
Q Global Advisors, LLC | 62,997 | $633,000 | 0.53% |
Soleus Capital Management, L.P. | 300,000 | $3,015,000 | 0.47% |
Bain Capital Life Sciences Investors, LLC | 700,000 | $7,035,000 | 0.44% |
COWEN AND COMPANY, LLC | 814,589 | $8,187,000 | 0.39% |
Kepos Capital LP | 530,000 | $5,327,000 | 0.36% |
Governors Lane LP | 412,042 | $4,141,000 | 0.28% |